SCHEMBL26530879

SCHEMBL26530879

Cc1cccc(-c2cncs2)c1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.40
TSHR P16473 1/20 0.40
HTT P42858 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
IDO1 P14902 1/20 0.37
CD38 P28907 1/20 0.36
NUDT1 P36639 2/20 0.36
BDKRB2 P30411 1/20 0.36
DYRK1A Q13627 2/20 0.36
TBXAS1 P24557 1/20 0.36
IMPDH2 P12268 1/20 0.36
HCRTR1 O43613 1/20 0.35
HCRTR2 O43614 1/20 0.35
DYRK2 Q92630 1/20 0.35
DYRK1B Q9Y463 1/20 0.35
P2RX7 Q99572 1/20 0.35
AR P10275 1/20 0.33
GRM5 P41594 1/20 0.33
ABL1 P00519 1/20 0.33
PDE10A Q9Y233 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16646852 0.85 KDM4E (0.44) KDM4ETSHRHTTNPSR1IDO1
SCHEMBL17194923 0.80 HTT (0.36) KDM4ETSHRHTTNPSR1IDO1
SCHEMBL26259995 0.78 TBXAS1 (0.44) KDM4EIDO1CD38BDKRB2DYRK1A
SCHEMBL6218537 0.77 ALDH1A1 (0.43) KDM4ETSHRHCRTR1HCRTR2
SCHEMBL1685064 0.76 PIK3CD (0.46) IDO1HCRTR1HCRTR2DYRK1B
SCHEMBL5509075 0.74 PLK1 (0.39) KDM4ECD38IMPDH2HCRTR1HCRTR2
SCHEMBL28019355 0.74 CYP2A6 (0.41) KDM4ETSHRHTTNPSR1IDO1
SCHEMBL26260003 0.73 IDO1 (0.45) KDM4ETSHRHTTIDO1BDKRB2
Hydrochloric Acid SCHEMBL6218930 0.73 MEN1 (0.41) IDO1IMPDH2HCRTR1HCRTR2GRM5
SCHEMBL28080111 0.71 KDM4E (0.49) KDM4EHTTNPSR1DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023180345-A1 TRICYCLIC PHTHALAZINES AND DERIVATIVES AS SOS1 INHIBITORS JAZZ PHARMACEUTICALS IRELAND LIMITED (IE) 2023-09-28 WO disclosed